search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
133 new news items in the last 24 hours
  1. Home
  2. International

Pfizer estimates an adjusted profit of $3-3.15 per share for 2025, but quarterly revenues have decreased by 6% to $16.65 billion

Miruna Brosban
whatsapp
facebook
linkedin
x
copy-link copy-link
5 November 2025, 16:02
main event image
International
ShU studio / Shutterstock.com
google-preference

Always see our news on Google

Pfizer has announced a revision of its profit forecast for 2025, now expecting an adjusted profit between $3 and $3.15 per share, compared to the previous estimate of $2.90–$3.10, due to solid performance and cost reductions. Quarterly revenues were $16.65 billion, slightly above estimates, but 6% lower than the previous year, influenced by decreased demand for the Comirnaty vaccine and the Paxlovid treatment. Net profit was $3.54 billion, impacted by a one-time tax of $1.35 billion. Pfizer maintains its total revenue estimate for 2025 between $61 and $64 billion and plans to cut costs by $7.7 billion by 2027. The company benefits from an agreement with the Trump administration to reduce drug prices in the U.S. in exchange for tariff exemptions. Pfizer is diversifying its portfolio through acquisitions in oncology and continues to develop drugs, despite declining sales of Covid products. Pfizer's shares have dropped by 7% since the beginning of the year.

Sources

sursa imagine
Profit.ro
Pfizer majorează prognoza de profit, în pofida scăderii vânzărilor
sursa imagine
News.ro
Pfizer a depăşit estimările privind rezultatele financiare şi a majorează prognoza de profit, în pofida scăderii vânzărilor
sursa imagine
Stiripesurse
Pfizer își majorează prognoza de profit, după rezultate peste așteptări în trimestrul trei

Latest News

14:40

Calea Victoriei records the highest rent increase in Europe, following an annual rise of 29%

14:22

Real Madrid has reached an agreement with Arda Guler to extend his contract

14:17

MoND has begun preparations for the December 1 parade / More than 2,000 military personnel and 130 pieces of military equipment will participate

13:59

Pete Hegseth visits Colombia for talks on military cooperation and shared security

13:49

ANRE: The number of prosumers rose to nearly 395,000 in September

See more news

NEWS ON THE SAME TOPICS

event image
Economy
PepsiCo cuts its 2026 profit forecast and announces new cost-cutting measures
event image
Economy
Volkswagen announces exceptional costs of 10 billion euros and reduces its estimated profit margin for 2026 to no more than 1%
event image
Economy
Stellantis shares rise after quarterly results beat expectations and the company reaffirmed its financial targets
event image
Economy
Nvidia reported a net profit more than double compared to last year. Revenues exceeded analysts' forecasts.
event image
Economy
OnlyFans reports a record profit of 714 million dollars in 2025
event image
Economy
Saudi Aramco giant's profit rose to 31.2 billion dollars in Q3 amid the war in Iran
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
Pfizer profit Income

Editor’s Recommendations

main event image
INSCOP Surveys
5 hours ago

November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter IX: Freedom vs. Security

main event image
Exclusive
4 hours ago

Exclusive Monitor of Ministers by NewsVibe: November 12–18, 2026 / Rogobete, Nazare and Neacșu top online visibility amid the Lyrica controversy and state-owned company reform

main event image
Politics
1 hour ago

Marian Neacșu Receives Expanded Powers in Government / The Deputy Prime Minister Will Review Projects from 15 Ministries and Coordinate Several Structures

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+4
main event image
International
1 hour ago

PHOTO After “old friend” Putin, Xi personally welcomes Trump at the airport. APEC Summit, between stabilizing relations and fears of a deal between the great powers

main event image
Current Affairs
2 hours ago

SUMMARY Earthquake alerts: why Japan warns the population before the arrival of strong seismic waves, while Romania does not use RO-Alert

main event image
Opinions
1 hour ago

Raed Arafat, a Mr. Bean at DSU

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol